2020
DOI: 10.34172/apb.2021.018
|View full text |Cite
|
Sign up to set email alerts
|

Self-nanoemulsifying Delivery of Andrographolide: Ameliorating Islet Beta Cells and Inhibiting Adipocyte Differentiation

Abstract: Introduction This study is a continuation of our previous research on increasing the dissolution and bioavailability of andrographolide self-nanoemulsifying (ASNE). The previous study showed that ASNE (15 mg/mL) demonstrated 12.0 ± 0.2 nm,-46.3 ± 4.2 mV, and 99.4% of particle size, zeta potential, and transmittance, respectively. This formulation is thermodynamically stable and significantly improved dissolution as opposed to andrographolide (AND) suspension. The ASNE also improves the AND bioavailability in r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 37 publications
0
2
1
Order By: Relevance
“…This might explain why A. paniculata treatment did not improve the characteristic features of canine DM in the present study. Furthermore, the findings of the current study were inconsistent with those of other rodent studies, which reported lowered glucose levels and decreased DM complications after treatment with A. paniculata and andrographolide ( Yu et al, 2003 ; Lee et al, 2010 ; Nugroho et al, 2012 ; Ji et al, 2016 ; Islam, 2017 ; Naik et al, 2017 ; Wediasari et al, 2020 ; Mehta et al, 2021 ; Syukri et al, 2021 ). However, the DM in rodents was chemically induced with streptozotocin or alloxan, which promotes cell death and decreases insulin production; this is different from the canine DM produced by chronic autoantibody destruction over a long period ( Al-awar et al, 2016 ; Furman, 2021 ; O’Kell et al, 2022 ).…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…This might explain why A. paniculata treatment did not improve the characteristic features of canine DM in the present study. Furthermore, the findings of the current study were inconsistent with those of other rodent studies, which reported lowered glucose levels and decreased DM complications after treatment with A. paniculata and andrographolide ( Yu et al, 2003 ; Lee et al, 2010 ; Nugroho et al, 2012 ; Ji et al, 2016 ; Islam, 2017 ; Naik et al, 2017 ; Wediasari et al, 2020 ; Mehta et al, 2021 ; Syukri et al, 2021 ). However, the DM in rodents was chemically induced with streptozotocin or alloxan, which promotes cell death and decreases insulin production; this is different from the canine DM produced by chronic autoantibody destruction over a long period ( Al-awar et al, 2016 ; Furman, 2021 ; O’Kell et al, 2022 ).…”
Section: Discussioncontrasting
confidence: 99%
“…A. paniculata , a medicinal plant typically used as an anti-inflammatory and antimicrobial agent, has been studied for its possible impact on the management of DM in humans ( Nugroho et al, 2012 ; Dai et al, 2019 ; Adiguna et al, 2021 ; Hossain et al, 2021 ). Andrographolide is a potential bioactive phytochemical in A. paniculata , which possesses antidiabetic properties ( Nugroho et al, 2012 ; Ji et al, 2016 ; Islam, 2017 ; Naik et al, 2017 ; Mehta et al, 2021 ; Syukri et al, 2021 ). Plasma andrographolide was detected in dogs orally treated with A. paniculata tablets, indicating that andrographolide can be absorbed via the GI tract ( Xu et al, 2015 ).…”
Section: Discussionmentioning
confidence: 99%
“…SNEDDS formulations have been widely used and shown to increase the solubility of embelin ( Parmar et al, 2015 ), nystatin ( Kassem et al, 2016 ), and adefovir dipivoxil ( Gupta et al, 2011 ). Meanwhile, andrographolide in self-nano emulsifying is reported effective to prevent diabetes by lowering blood glucose levels, ameliorating islet beta cells, and inhibiting lipid formation in adipocyte cells ( Syukri et al, 2021b ).…”
Section: Introductionmentioning
confidence: 99%